Affymetrix Stock Lifted by New CEO Appointment

Shares of the company climbed as much as 13 percent, and in an analyst note, R.W. Baird said incoming CEO Frank Witney could return Affymetrix to top-line growth.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.